| Market Capitalization (Millions $) |
0 |
| Shares
Outstanding (Millions) |
1 |
| Employees |
7 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-9 |
| Cash Flow (TTM) (Millions $) |
-9 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Ampio Pharmaceuticals Inc. is a biopharmaceutical company that focuses on the development of therapies for the treatment of inflammatory and metabolic diseases. The company's main goal is to improve the quality of life for patients suffering from these conditions.
Ampio Pharmaceuticals develops its therapies using a proprietary drug delivery technology called Ampion. This technology allows for the targeted delivery of therapeutic compounds to the site of inflammation, which can help reduce pain and inflammation in affected tissues.
The company's pipeline includes several drug candidates that are being developed for various indications, including osteoarthritis, diabetic macular edema, and respiratory diseases. Ampio Pharmaceuticals is currently conducting clinical trials to evaluate the safety and efficacy of these therapies.
In addition to its drug development efforts, Ampio Pharmaceuticals also collaborates with other pharmaceutical companies and research organizations to explore potential collaborations and licensing agreements.
Overall, Ampio Pharmaceuticals is dedicated to advancing innovative therapies that have the potential to make a significant impact on the lives of patients with inflammatory and metabolic diseases.
Company Address: 9800 Mount Pyramid Court Englewood 80112 CO
Company Phone Number: 437-6500 Stock Exchange / Ticker: NYSEAMER AMPE
|
0.000%
2.07% 